Correction to: Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys

Alice M Biggane^{1

2}, Lucy Brading³, Philippe Ravaud^{4

5

6

7}, Bridget Young⁸, Paula R Williamson⁹

Affiliations

¹ Department of Biostatistics, University of Liverpool, Liverpool, UK. abiggane@liverpool.ac.uk.
² INSERM, U1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Methods of Therapeutic Evaluation of Chronic Diseases (METHODS) Team, Paris Descartes University, Sorbonne Paris Cité, Paris, France. abiggane@liverpool.ac.uk.
³ Institute of Psychology Health and Society/North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, UK.
⁴ Centre de Recherche Epidémiologie et Statistique, INSERM U1153, Paris, France.
⁵ Cochrane France, Paris, France.
⁶ Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, 75004, Paris, France.
⁷ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
⁸ Department of Psychological Sciences and MRC North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, UK.
⁹ MRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, UK.

Published Erratum

Alice M Biggane et al. Trials. 2018.

. 2018 Aug 8;19(1):430.

doi: 10.1186/s13063-018-2595-6.

Alice M Biggane^{1

2}, Lucy Brading³, Philippe Ravaud^{4

5

6

7}, Bridget Young⁸, Paula R Williamson⁹

¹ Department of Biostatistics, University of Liverpool, Liverpool, UK. abiggane@liverpool.ac.uk.
² INSERM, U1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Methods of Therapeutic Evaluation of Chronic Diseases (METHODS) Team, Paris Descartes University, Sorbonne Paris Cité, Paris, France. abiggane@liverpool.ac.uk.
³ Institute of Psychology Health and Society/North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, UK.
⁴ Centre de Recherche Epidémiologie et Statistique, INSERM U1153, Paris, France.
⁵ Cochrane France, Paris, France.
⁶ Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, 75004, Paris, France.
⁷ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
⁸ Department of Psychological Sciences and MRC North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, UK.
⁹ MRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, UK.

Abstract

In the original publication [1] the abbreviation for Core outcome sets (COS) was pluralized unnecessarily throughout the next.

Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.
Biggane AM, Brading L, Ravaud P, Young B, Williamson PR. Biggane AM, et al. Trials. 2018 Feb 17;19(1):113. doi: 10.1186/s13063-018-2493-y. Trials. 2018. PMID: 29454368 Free PMC article.

1. Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys. Trials. 2018;19:113. 10.1186/s13063-018-2493-y. - PMC - PubMed